Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase III for Bullous Pemphigoid. According to GlobalData, Phase III drugs for Bullous Pemphigoid does not have ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has reached over $13bn in global sales, which affirms its commercial advantage and sets a milestone for ...

In this episode, Claudia reexamines a story about inhalable flu vaccines that she had found in the New Scientist edition from March 11th, 1995. Normally, vaccines are administered via injections ...

Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China School of Materials Science and Engineering, Tongji University, Shanghai ...

Researchers from POSTECH and Kyungpook National University have developed a novel inhalable therapeutic delivery system for lung cancer, leveraging mucoadhesive protein nanoparticles inspired by the ...

Get Instant Summarized Text (Gist) A novel inhalable therapeutic delivery system for lung cancer has been developed using mucoadhesive protein nanoparticles inspired by marine mussels. These ...

Scientists have developed inhalable lung cancer therapeutics utilizing mucoadhesive proteinic nanoparticles. Researchers from POSTECH and Kyungpook National University have developed a novel ...

Department of Electrical and Computer Engineering, National Yang Ming Chiao Tung University, Hsinchu 30010, Taiwan Institute of Biomedical Engineering, College of Electrical and Computer Engineering, ...